Nebenwirkungen · Neupro
Neupro 2 mg/24 h 4 mg/24 h 6 mg/24 h 8 mg/24 h Transdermal patch · Abschnitt 4.8 · PDF-Seite 55–56
HOS-114754 · Präparat HOS-094135
55 Vascular Orthostatic Hypotension disorders hypotension, hypertension Respiratory, Hiccups thoracic and mediastinal disorders Gastrointestinal Nausea, Constipation, Abdominal pain Diarrhoeac disorders vomiting dry mouth, dyspepsia Skin and Erythema, Pruritus Rash subcutaneous hyperhidrosis, generalised, skin generalised tissue disorders pruritus irritation, dermatitis contact Reproductive Erectile system and dysfunction breast disorder General Application and Oedema Irritability disorders and instillation site peripheral, administration reactionsa (incl. asthenic site conditions erythema, conditionsa pruritus, (incl. fatigue, irritation, rash, asthenia, dermatitis, malaise) vesicles, pain, eczema, inflammation, swelling, discolouration, papules, exfoliation, urticaria, hypersensitivity) Investigations Weight Hepatic enzyme decreased increased (incl. AST, ALT, GGT), weight increased, heart rate increased, CPK increasedd Injury, Fall poisoning and procedural complications Musculoskeletal Rhabdomyolysisc and connective tissue disorders a High Level Term b Observed in open-label studies c Observed during post-marketing d Observed in 2011 data pool of double-blind placebo-controlled studies
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-07T15:00:00Z · SHA-256 8c1c13f4377b291e92778d0cf7bf84640db85e338315a5f9bf30e0c0a33c9a3d · Passage ebad84b89766eba5617698dc4b3503f37e6a04be87dcb4ced6ab129098f3cf43 · Zeichen 4884–7465 im Abschnitt